LECs isolated from a patient with GLA showed increased survival and proliferation, an inability to properly form vascular networks, and elevated AKT and ERK phosphorylation levels which could be lowered with rapamycin and trametinib, respectively [28]. The gene discussed is AKT1; the disease is diffuse lymphatic malformation.